RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Results From LUMINOUS, a Global Real-World Study

PURPOSE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naive patients with neovascular age-related macular degeneration enrolled in LUMINOUS study. METHODS: This 5-year, prospective, multicenter, observational study recruited 30,138 adult patients (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retina
Main Authors: Holz, Frank G., Figueroa, Marta S., Bandello, Francesco, Yang, Yit, Ohji, Masahito, Dai, Hong, Wykrota, Halina, Sharma, Sanjay, Dunger-Baldauf, Cornelia, Lacey, Sue, Macfadden, Wayne, Mitchell, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Retina 2020
Assuntos:
Original Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447127/
https://ncbi.nlm.nih.gov/pubmed/31764612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000002670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados